What question did this study set out to answer?

March 24, 2026Scripta MedicaOpen Access

The silent crisis: Economic burden of genetic disease diagnosis in lowand middle-income countries (LMICs)

View Full Paper

Ask AI

Bookmark

Authors

Narrative review details the economic impact of genetic disorder diagnosis in LMICs, indicating urgent need for improvement.

To explore the economic burden of genetic disease diagnosis in low and middle-income countries.
Conducted a narrative review of economic costs associated with genetic disorder diagnosis.
Analyzed both direct and indirect costs related to molecular diagnostics in LMICs.
Examined the impact of misdiagnosis and productivity loss on families and society.
Identified significant direct costs due to advanced molecular diagnostics and reliance on foreign services.
Highlighted the lengthy diagnostic odyssey as a major indirect cost affecting patients and families.
Suggested improvements through local capacity building and innovative finance models.

Baig et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

March 24, 2026Scripta MedicaOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Narrative review details the economic impact of genetic disorder diagnosis in LMICs, indicating urgent need for improvement.

To explore the economic burden of genetic disease diagnosis in low and middle-income countries.
Conducted a narrative review of economic costs associated with genetic disorder diagnosis.
Analyzed both direct and indirect costs related to molecular diagnostics in LMICs.
Examined the impact of misdiagnosis and productivity loss on families and society.
Identified significant direct costs due to advanced molecular diagnostics and reliance on foreign services.
Highlighted the lengthy diagnostic odyssey as a major indirect cost affecting patients and families.
Suggested improvements through local capacity building and innovative finance models.

Baig et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark